SCHEMBL3774604

SCHEMBL3774604

O=C(Nc1noc2ccccc12)N1CCN(c2nc(N3CCOCC3)ns2)CC1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FAAH O00519 18/20 0.70
EPHX2 P34913 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3767913 0.92 FAAH (0.73) FAAHEPHX2
SCHEMBL3766352 0.91 FAAH (0.75) FAAHEPHX2
SCHEMBL3772067 0.91 FAAH (0.72) FAAHEPHX2
SCHEMBL3765495 0.90 FAAH (0.69) FAAHEPHX2
SCHEMBL3767456 0.89 FAAH (0.68) FAAHEPHX2
Hydrochloric Acid SCHEMBL3770663 0.89 FAAH (0.68) FAAHEPHX2
SCHEMBL3765888 0.87 FAAH (0.69) FAAHEPHX2
Hydrochloric Acid SCHEMBL3761612 0.87 FAAH (0.66) FAAHEPHX2
Hydrochloric Acid SCHEMBL3765760 0.87 FAAH (0.66) FAAHEPHX2
SCHEMBL3767891 0.87 FAAH (0.65) FAAHEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851473-B2 Amide compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-14 US disclosed
US-20080312226-A1 Amide Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-18 US disclosed
EP-1813606-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312226-A1 Amide Compound FAAH, FAAH2, CNR2 FAAH 1/4885EPHX2 392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.